Bayer to bolster plant biotech operations, exec says

09/18/2009 | Reuters

Bayer needs to strengthen its biotech seed operations because of gradual convergence in conventional and new techniques in crop protection, said Friedrich Berschauer, head of Bayer's CropScience unit. Bayer, which seeks to triple annual sales of bioengineered seeds to $2.1 billion by 2018, aims to become the world's third or fourth largest supplier of biotech seeds in a decade, said Ruediger Scheitza, CropScience's strategy chief.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Litigation
Center for Science in the Public Interest
Washington, DC
Health Plan CEO - Oregon
Trillium Community Health Plan
Eugene, OR
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Associate General Counsel
Patient-Centered Outcomes Research Institute
Washington, D.C , DC